The purpose of this study was to examine the association between perceived family support, either positive or negative, and adherence to antiretroviral medication regimens among HIV-positive individuals in the Kathmandu Valley, Nepal. We measured past 3-month antiretroviral adherence among 233 HIV-positive individuals, in relation to perceived family support, both positive (in terms of emotional and instrumental support) and negative (in the form of negative interactions), using the 10-item Nepali Family Support and Difficulty Scale. Medium and high levels of perceived emotional support from family were associated with reduced risk of antiretroviral nonadherence, compared with low levels of perceived emotional support (adjusted odds ratio [AOR] = 0.37, 95% confidence interval [CI] [0.16, 0.88], and AOR = 0.23, 95% CI [0.08, 0.64], respectively). Conversely, higher levels of felt emotional distance (AOR = 1.46, 95% CI [1.00, 2.14]) and experienced physical harm (AOR = 2.04, 95% CI [1.07, 3.91]) were associated with increased risk of nonadherence. The results support the recommendation that service providers need to be aware of the significant role of family support in shaping antiretroviral adherence and to consider ways to strengthen positive family support while minimizing negative family interactions to increase adherence rates.
Collaboration C. Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet2000; 355: 1158–1159.
2.
GortmakerSLHughesMCerviaJ. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med2001; 345: 1522–1528.
3.
HoggRSHeathKVYipB. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA1998; 279: 450–454.
4.
PalellaFJJrDelaneyKMMoormanAC. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med1998; 338: 853–860.
5.
PasternakAOde BruinMJurriaansS. Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis2012; 206: 1443–1452.
6.
SethiAKCelentanoDDGangeSJ. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis2003; 37: 1112–1118.
7.
PatersonDLSwindellsSMohrJ. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med2000; 133: 21–30.
8.
ChesneyM. Adherence to HAART regimens. AIDS Patient Care STDS2003; 17: 169–177.
9.
Haubrich RH, Hirsch M, Flexner C, et al. Effect of antiretroviral discontinuation and reintroduction on markers of HIV infection. In: 2nd Annual national conference on human retroviruses and related infections, 29 January–2 Febrary, Washington DC, USA, 1995.
10.
GiffordALBormannJEShivelyMJ. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr2000; 23: 386–395.
11.
Rotheram-BorusMJSteinJAJiraphongsaC. Benefits of family and social relationships for Thai parents living with HIV. Prev Sci2010; 11: 298–307.
12.
CupsaAGheoneaCBuluceaD. Factors with a negative influence on compliance to antiretroviral therapies. Ann N Y Acad Sci2000; 918: 351–354.
13.
DongKThabetheZHurtadoR. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa. J Infect Dis2007; 196(Suppl 3): S491–S496.
14.
SellierPClevenberghPLjubicicL. Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa. Clin Infect Dis2006; 43: 654–657.
15.
ShorERoelfsDJYogevT. The strength of family ties: a meta-analysis and meta-regression of self-reported social support and mortality. Soc Networks2013; 35: 626–638.
16.
UshieBAJegedeAS. The paradox of family support: concerns of tuberculosis-infected HIV patients about involving family and friends in their treatment. AIDS Patient Care STDS2012; 26: 674–680.
17.
LiLWuSWuZ. Understanding family support for people living with HIV/AIDS in Yunnan, China. AIDS Behav2006; 10: 509–517.
18.
VeielHOFBaumannU. The meaning and measurement of social support, New York, NY: Hemisphere Publication Services, 1992.
19.
BadahdahAMPedersenDE. “I want to stand on my own legs”: a qualitative study of antiretroviral therapy adherence among HIV-positive women in Egypt. AIDS Care2011; 23: 700–704.
20.
CastroROrozcoEAggletonP. Family responses to HIV/AIDS in Mexico. Soc Sci Med1998; 47: 1473–1484.
21.
LiLSunSWuZ. Disclosure of HIV status is a family matter: field notes from China. J Fam Psychol2007; 21: 307–314.
22.
SongwathanaPMandersonL. Stigma and rejection: living with AIDS in villages in southern Thailand. Med Anthropol2001; 20: 1–23.
23.
ObirikorangCSellehPKAbleduJK. Predictors of adherence to antiretroviral therapy among HIV/AIDS patients in the upper west region of Ghana. ISRN AIDS2013; 2013: 873939.
24.
RaoDKekwaletsweTCHosekS. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care2007; 19: 28–33.
25.
WoodwardENPantaloneDW. The role of social support and negative affect in medication adherence for HIV-infected men who have sex with men. J Assoc Nurses AIDS Care2012; 23: 388–396.
26.
WrubelJStumboSJohnsonMO. Antiretroviral medication support practices among partners of men who have sex with men: a qualitative study. AIDS Patient Care STDS2008; 22: 851–858.
27.
McCubbinHIThompsonAIElverKM. Family attachment and changeability index 8 (FACI 8), Madison, WI: University of Wisconsin Publishers, 1996.
28.
WoutersEMeulemansHvan RensburgHC. Slow to share: social capital and its role in public HIV disclosure among public sector ART patients in the free state province of South Africa. AIDS Care2009; 21: 411–421.
29.
PoudelKCPalmerPHJimbaM. Coinfection with hepatitis C virus among HIV-positive people in the Kathmandu Valley, Nepal. J Int Assoc Provid AIDS Care2014; 13: 277–283.
30.
PoudelKCBuchananDRPoudel-TandukarK. Effects of a community-based HIV risk reduction intervention among HIV-positive individuals: results of a quasi-experimental study in Nepal. AIDS Educ Prev2015; 27: 240–256.
31.
Poudel-TandukarKPoudelKCJimbaM. Serum 25-hydroxyvitamin d levels and C-reactive protein in persons with human immunodeficiency virus infection. AIDS Res Hum Retroviruses2013; 29: 528–534.
32.
Poudel-TandukarKBertone-JohnsonERPalmerPH. C-reactive protein and depression in persons with human immunodeficiency virus infection. Brain Behav Immun2014; 42: 89–95.
33.
Poudel KC, Bertone-Johnson ER and Poudel-Tandukar K. Serum zinc concentration and C-reactive protein in individuals with human immunodeficiency virus infection: The positive living with HIV (POLH) study. Biol Trace Elem Res. Epub ahead of print 1 October 2015. DOI:10.1007/s12011-015-0520-3.
34.
CBS. Population census 2011, preliminary results, Kathmandu, Nepal: Central Bureau of Statistics, 2011.
35.
Fujita M, Poudel KC, Green K, et al. HIV service delivery models towards ‘Zero AIDS-related Deaths’: A collaborative case study of 6 Asia and Pacific countries. BMC Health Serv Res 2015; 15: 176. DOI:10.1186/s12913-015-0804-5.
36.
NCASC. National estimates of HIV infections in Nepal 2012, Kathmandu, Nepal: National Center for AIDS and STD Control, Ministry of Health and Population, 2012.
37.
NCASC. Nepal country progress report 2012: to contribute to global AIDS response progress report 2012, Kathmandu, Nepal: National Center for AIDS and STD Control, Ministry of Health and Population, 2012.
PoudelKCNakaharaSPoudel-TandukarK. Unsafe sexual behaviors among HIV-positive men in Kathmandu Valley, Nepal. AIDS Behav2009; 13: 1143–1150.
40.
PoudelKCOkumuraJSherchandJB. Mumbai disease in far western Nepal: HIV infection and syphilis among male migrant-returnees and non-migrants. Trop Med Int Health2003; 8: 933–939.
41.
PoudelKCPoudel-TandukarKNakaharaS. Knowing the consequences of unprotected sex with seroconcordant partner is associated with increased safer sex intentions among HIV-positive men in Kathmandu, Nepal. J Health Popul Nutr2011; 29: 191–199.
42.
PoudelKCPoudel-TandukarKYasuokaJ. Correlates of sharing injection equipment among male injecting drug users in Kathmandu, Nepal. Int J Drug Policy2010; 21: 507–510.
43.
ShresthaSPoudelKCPoudel-TandukarK. Perceived family support and depression among people living with HIV/AIDS in the Kathmandu Valley, Nepal. J Int Assoc Provid AIDS Care2014; 13: 214–222.
44.
AmiyaRMPoudelKCPoudel-TandukarK. Perceived family support, depression, and suicidal ideation among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley, Nepal. PLoS One2014; 9: e90959.
45.
KohrtBA. Political violence and mental health in Nepal: war in context, structural violence, and the erasure of history, Atlanta, GA: Department of Anthropology, Emory University, 2009.
46.
AmiyaRMPoudelKCPoudel-TandukarK. Physicians are a key to encouraging cessation of smoking among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley, Nepal. BMC Public Health2011; 11: 677.
47.
MartinCPoudel-TandukarKPoudelKC. HIV symptom burden and anemia among HIV-positive individuals: cross-sectional results of a community-based positive living with HIV (POLH) study in Nepal. PLoS One2014; 9: e116263.
48.
JusticeACHolmesWGiffordAL. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol2001; 54(Suppl 1): S77–S90.
49.
SimbayiLCKalichmanSStrebelA. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa. Soc Sci Med2007; 64: 1823–1831.
50.
KohrtBAKunzRDKoiralaRN. Validation of a Nepali version of the Beck Depression Inventory. Nep J Psychiatry2009; 2: 123–130.
51.
KohrtBASpeckmanRAKunzRD. Culture in psychiatric epidemiology: using ethnography and multiple mediator models to assess the relationship of caste with depression and anxiety in Nepal. Ann Hum Biol2009; 36: 261–280.
52.
KatzMH. Multivariable analysis: a practical guide for clinicians and public health researchers, 3rd ed. New York, NY: Cambridge University Press, 2011.
53.
MfundisiCChiranjanNRodriguesC. Availability of antiretroviral therapy is associated with increased uptake of HIV testing services. S Afr Med J2005; 95: 483–485.
54.
WoutersEMasquillierCPonnetK. A peer adherence support intervention to improve the antiretroviral treatment outcomes of HIV patients in South Africa: the moderating role of family dynamics. Soc Sci Med2014; 113: 145–153.
55.
Fredriksen-GoldsenKIShiuCSStarksH. “You must take the medications for you and for me”: family caregivers promoting HIV medication adherence in China. AIDS Patient Care STDS2011; 25: 735–741.
56.
VenkateshKKSrikrishnanAKMayerKH. Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS2010; 24: 795–803.
57.
ShigdelRKloumanEBhandariA. Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal. HIV AIDS (Auckl)2014; 6: 109–116.
58.
BergKMDemasPAHowardAA. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med2004; 19: 1111–1117.
59.
ThamesADMoizelJPanosSE. Differential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV-positive drug-using adults. AIDS Patient Care STDS2012; 26: 621–630.
60.
IngersollK. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care2004; 16: 199–211.
61.
CohenSWillsTA. Stress, social support, and the buffering hypothesis. Psychol Bull1985; 98: 310–357.
62.
SerovichJMKimberlyJAMosackKE. The role of family and friend social support in reducing emotional distress among HIV-positive women. AIDS Care2001; 13: 335–341.
